Effects of tamoxifen on DNA adduct formation and arylamines N-acetyltransferase activity in human breast cancer cells

Research Communications in Molecular Pathology and Pharmacology

Volumn 115-116, Issue , 2004, Pages 217-233

  Lee, Jau Hong ^a   Lu, Hsu Feng ^b   Wang, Der Yean ^a   Chen, Dar Ren ^a   Su, Chin Cheng ^a   Chen, Yi Shuan ^c   Yang, Jen Hung ^d   Chung, Jing Gung ^c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

2 aminofluorene; Breast cancer cells; N acetyl 2 amonofluorence; N acetyltransferase; Tamoxifen

Indexed keywords

2 FLUORENYLAMINE; ARYLAMINE ACETYLTRANSFERASE; ESTROGEN RECEPTOR; TAMOXIFEN; 2-AMINOFLUORENE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CARCINOGEN; FLUORENE DERIVATIVE; UNCLASSIFIED DRUG;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA ADDUCT; DRUG DNA INTERACTION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; BIOSYNTHESIS; BREAST TUMOR; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; KINETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ACETYLATION; ANTINEOPLASTIC AGENTS, HORMONAL; ARYLAMINE N-ACETYLTRANSFERASE; BREAST NEOPLASMS; CARCINOGENS; CELL LINE, TUMOR; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORENES; HUMANS; KINETICS; RECEPTORS, ESTROGEN; TAMOXIFEN;

EID: 34447291564     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ambrosone, C.B., Freudenheim, J.L., Graham, S., Marshall, J.R., Vena, J.E., Brasure, JR, Michalek, A.M., Laughlin, R., Nemoto, T., Gillenwater, K.A., and Shields, P.G. (1996). Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA. 276: 1494-1501.
2. Bartsch, H., Phillips, D.H., Nair, J., Hewer, A., Meyberg-Solomeyer, G., Grischke, and E.M. (2000). Lack of evidence for tamoxifen- and toremifene-DNA adducts in lymphocytes of treated patients. Carcinogenesis. 21: 845-847.
3. Beland, F.A., Melchior, W.B.J., Mourato, L.L., Santos, M.A., and Marques, M.M. (1997). Arylamine-DNA adduct conformation in relation to mutagenesis. Mutat Res. 376: 13-19.
4. Chung, J.G., Levy, G.N., and Weber, W. W. (1993). Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice. Drug Meta & Disposition. 21: 1057-1063.
5. Cleland, W.W. (1967). The statistical analysis of enzyme kinetic data. Adv Enzymology & Related Areas of Mol Biol. 29: 1-32.
6. De Flora, S., Balansky, R., Scatolini, L., Di Marco, C., Gasparini, L., Orlando, M., and Izzotti, A. (1996). Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention. IARC Scientific Publications (Lyon), pp 291-301.
7. Debiec-Rychter, M., Tada, M., Poirier, M.C., and Wang, C.Y. (1998). DNA adduct formation in human and rat mammary epithelium by N-hydroxy derivatives of 2-aminofluorene and 4-aminobiphenyl. Teratogenesis, Carcinogenesis, & Mutagenesis. 18: 35-39.
8. Debiec-Rychter, M., Land, S.J., and King, C.M. (1999). Histological localization of acetyltransferases in human tissue. Cancer Lett. 143:99-102.
9. Delfino, R.J., Sinha, R., Smith, C., West, J., White, E., Lin, H.J., Liao, S.Y., Gim, JS, Ma, H.L., Butler, J., and Anton-Culver, H. (2000). Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype. Carcinogenesis. 21:607-615.
10. Einisto, P., Watanabe, M., Ishidate, M.J., and Nohmi, T. (1991). Mutagenicity of 30 chemicals in Salmonella typhimurium strains possessing different nitroreductase or O-acetyltransferase activities. Mutat Res. 259: 95-102.
11. Fisher, B., Costantino, J.P., Wickerham, D.L., Redmond, C.K., Kavanah, M., Cronin, W.M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan, C., Ford, L., and Wolmark, N. (1998). Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Institute. 90: 1371-1388, 1998.
12. Garner, R.C. (1998). The role of DNA adducts in chemical carcinogenesis. Mutat Res. 402: 67-75.
13. Gertig, D.M., Hankinson, S.E., Hough, H., Spiegelman, D., Colditz, G.A., Willett, W.C., Kelsey, K.T., and Hunter, D.J. (1999). N-acetyl transferase 2 genotypes, meat intake and breast cancer risk. Internat J Cancer. 80: 13-17.
14. Gupta, R.C. (1988). 32P-adduct assay: short- and long-term persistence of 2-acetylaminofluorene-DNA adducts and other applications of the assay. Cell Biol Toxicol. 4: 467-474.
15. Heel, R.C., Brogden, R.N., Speight, T.M., and Avery, G.S. (1978). Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer. Drugs. 16: 1-24.
16. Hemminki, K., Rajaniemi, H., Lindahl, B., and Moberger, B. (1996). Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients [see comments]. Cancer Res. 56:4374-4377.
17. Hemminki, K., Rajaniemi, H., Koskinen, M., and Hansson, J. (1997). Tamoxifen-induced DNA adducts in leucocytes of breast cancer patients. Carcinogenesis. 18: 9-13.
18. Huang, C.S., Chern, H.D., Shen, C.Y., Hsu, S.M., and Chang, K.J. (1999). Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence. International J Cancer. 82: 175-179.
19. King, C.M., Land, S.J., Jones, R.F., Debiec-Rychter, M., Lee, M.S., and Wang, C.Y. (1997). Role of acetyltransferases in the metabolism and carcinogenicity of aromatic amines. Mutat Res. 376: 123-128.
20. Lee, J.H., Chung, J.G., Lai, J.M., Levy, G.N., and Weber, W.W. (1997). Kinetics of arylamine N-acetyltransferase in tissues from human breast cancer. Cancer Lett. 111:39-50.
21. 32P-postlabeled DNA-aromatic carcinogen adducts. Analyt Biochem. 174:381-392.
22. Levy, G.N., Chung, J.G., and Weber, W.W. (1994). 2-Aminofluorene metabolism and DNA adduct formation by mononuclear leukocytes from rapid and slow acetylator mouse strains. Carcinogenesis. 15: 353-357.
23. Li, D., Wang, M., Dhingra, K., and Hittelman, W.N. (1996). Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res. 56: 287-293.
24. Li, D., Zhang, W., Sahin, A.A., and Hittelman, W.N. (1999). DNA adducts in normal tissue adjacent to breast cancer: a review. Cancer Detection & Prevention. 23: 454-462.
25. Otteneder, M. and Lutz, W.K. (1999). Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts. Mutat Res. 424: 237-247.
26. Perera, F.P., Estabrook, A., Hewer, A., Channing, K., Rundle, A., Mooney, L.A., Whyatt, R., and Phillips, D.H. (1995). Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiology, Biomarkers & Prevention. 4: 233-238.
27. Pfau, W., Stone, E.M., Brockstedt, U., Carmichael, P.L., Marquardt, H., and Phillips, D.H. (1998). DNA adducts in human breast tissue: association with N-acetyltransferase-2 (NAT2) and NAT1 genotypes. Cancer Epidemiology, Biomarkers & Prevention. 7: 1019-1025.
28. Phillips, D.H., Hewer, A., Grover, P.L., Poon, G.K., and Carmichael, P.L. (1996). Tamoxifen does not form detectable DNA adducts in white blood cells of breast cancer patients. Carcinogenesis. 17: 1149-1152.
29. Poirier, M.C., Fullerton, N.F., Kinouchi, T., Smith, B.A., Beland, F.A. (1991). Comparison between DNA adduct formation and tumorigenesis in livers and bladders of mice chronically fed 2-acetylaminofluorene. Carcinogenesis, 12: 895-900.
30. Poirier, M.C. and Beland, F.A. (1994). DNA adduct measurements and tumor incidence during chronic carcinogen exposure in rodents. Environmental Health Perspectives. 102 Suppl 6: 161-165.
31. Poirier, M.C. (1997). DNA adducts as exposure biomarkers and indicators of cancer risk. Environmental Health Perspectives. 105 Suppl 4: 907-912.
32. Santella, R.M., Gammon, M.D., Zhang, Y.J., Motykiewicz, G., Young, T.L., Hayes, S.C, Terry, M.B., Schoenberg, J.B., Brinton, L.A., Bose, S., Teitelbaum, S.L., and Hibshoosh, H. (2000). Immunohistochemical analysis of polycyclic aromatic hydrocarbon-DNA adducts in breast tumor tissue. Cancer Lett. 154: 143-149.
33. Synderwine, E.G. (1996). The food-derived heterocyclic amines and breast cancer: a 1995 Perspective. Recent Results in Cancer Research. 140: 17-257.
34. Tagnon, H.J. (1997). Antiestrogens in treatment of breast cancer. Cancer. 39: 2959-2964.
35. Weber, W.W. and Hein, D.W. (1985). N-acetylation pharmacogenetics. PharmacolRev. 37: 25-79.
36. Zheng, O., Lutz, W.K., and Gaylor, D.W. (1997). A carcinogenesis model describing mutational events at the DNA adduct level. Math Biosciences. 144: 23-44.
37. Zheng, W., Deitz, A.C., Campbell, D.R., Wen, W.Q., Cerhan, J.R., Sellers, T.A., Folsom, AR, and Hein, D.W. (1999). N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention. 8: 233-239.